Seeking value primarily in developed markets worldwide

The global value portfolio is constructed from an equity universe composed of companies with market capitalizations typically greater than $1 billion located throughout the global developed and emerging market countries. Through rigorous, bottom-up company analysis, we seek to identify undervalued stocks with upside potential. The investment process comprises three stages: quantitative screening and initial analysis, fundamental research and portfolio construction.

Benchmark
MSCI ACWI
Inception
September 30, 2001
Download Profile Sheet Download Flash Report Download Quarterly Review Risk Disclosures
Contact Us

Strategy overview

The portfolio managers discuss our Global Value strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 2.4%16.9%19.2%20.9%19.6%9.6%11.0%
Strategy (net) 2.4%16.6%18.7%20.4%19.1%9.1%10.3%
MSCI ACWI 1.4%11.9%16.4%15.8%13.3%10.6%8.8%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 2.4%16.9%19.2%20.9%19.6%9.6%11.0%
Strategy (net) 2.4%16.6%18.7%20.4%19.1%9.1%10.3%
MSCI ACWI 1.4%11.9%16.4%15.8%13.3%10.6%8.8%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 10.9%14.1%21.1%22.3%19.0%9.5%10.9%
Strategy (net) 10.8%13.9%20.6%21.8%18.4%9.0%10.3%
MSCI ACWI 11.7%10.3%16.7%17.9%14.2%10.5%8.8%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 10.9%14.1%21.1%22.3%19.0%9.5%10.9%
Strategy (net) 10.8%13.9%20.6%21.8%18.4%9.0%10.3%
MSCI ACWI 11.7%10.3%16.7%17.9%14.2%10.5%8.8%
Fund 2024202320222021202020192018201720162015201420132012201120102009
Strategy (gross) 14.2%30.3%-12.7%18.0%4.9%23.0%-10.0%18.8%8.7%-5.4%7.1%31.8%18.3%-0.2%19.8%41.7%
Strategy (net) 13.8%29.8%-13.1%17.4%4.4%22.4%-10.4%18.3%8.2%-5.8%6.7%31.2%17.4%-1.1%18.8%40.5%
MSCI ACWI 18.0%22.8%-18.0%19.0%16.8%27.3%-8.9%24.6%8.5%-1.8%4.7%23.4%16.8%-6.9%13.2%35.4%
Table Header
Strategy (gross)
Strategy (net)
MSCI ACWI
2024202320222021202020192018201720162015201420132012201120102009
14.2%30.3%-12.7%18.0%4.9%23.0%-10.0%18.8%8.7%-5.4%7.1%31.8%18.3%-0.2%19.8%41.7%
13.8%29.8%-13.1%17.4%4.4%22.4%-10.4%18.3%8.2%-5.8%6.7%31.2%17.4%-1.1%18.8%40.5%
18.0%22.8%-18.0%19.0%16.8%27.3%-8.9%24.6%8.5%-1.8%4.7%23.4%16.8%-6.9%13.2%35.4%

Portfolio (as of July 31, 2025)

Benchmark: MSCI ACWI
Asset Allocation
Table Header Strategy
Stocks 99.5%
Cash 0.5%
Strategy Characteristics
Table Header Strategy Benchmark
No. of holdings 55 2524
Weighted avg. market cap (US $MM) $157,287 $769,024
FY2 price/earnings 13.0 17.8
Price/book value 1.9 3.4
Dividend yield (%) 2.0 1.8
TOP 10 HOLDINGS
Security Country Percent
Samsung Electronics Co., Ltd. South Korea 4.5%
Kering SA France 4.4%
Alphabet, Inc. United States 3.9%
Alstom SA France 3.6%
Reckitt Benckiser Group Plc United Kingdom 3.4%
Rolls-Royce Holdings Plc United Kingdom 3.2%
Renesas Electronics Corp. Japan 3.1%
Citigroup, Inc. United States 3.0%
Infineon Technologies AG Germany 2.7%
Carnival Corp. United States 2.6%

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Strategy Benchmark
Information Technology 22.9% 26.6%
Financials 15.3% 17.7%
Consumer Discretionary 11.8% 10.4%
Industrials 11.6% 11.0%
Health Care 11.1% 8.5%
Communication Services 10.5% 8.6%
Consumer Staples 6.6% 5.6%
Materials 5.0% 3.4%
Utilities 2.1% 2.6%
Real Estate 1.6% 1.9%
Energy 1.0% 3.6%
TOP 10 COUNTRIES
Country Strategy Benchmark
United States 41.9% 64.9%
United Kingdom 18.9% 3.3%
France 8.7% 2.4%
Japan 7.7% 4.7%
Germany 5.5% 2.3%
Netherlands 4.7% 1.0%
South Korea 4.5% 1.2%
Canada 2.1% 2.8%
China 1.9% 3.1%
Sweden 1.4% 0.8%
Regional Allocation
  • North America 44.0%
  • Euro 20.4%
  • Europe - Other 20.3%
  • Pacific 7.7%
  • Emerging Asia 6.4%
  • Emerging Europe, Middle East, Africa 0.7%

Commentary (As of July 31, 2025)

Highlights

  • US technology stocks led global markets higher in July, but value generally outperformed growth in developed international markets.
  • Causeway’s global and international value portfolios focus on identifying undervalued stocks rather than positioning around macroeconomic trends. Given the valuation gap between US and non-US markets, we are aiming to find some of the most compelling investment opportunities across international markets.
  • Our focus remains on identifying companies that offer durable value, characterized by pricing power, iconic brands, or robust product pipelines.

Portfolio Attribution

The Portfolio outperformed the Index during the month, due primarily to stock selection. Portfolio holdings in the technology hardware & equipment, banks, and household & personal products industry groups contributed to relative performance. Holdings in the semiconductors & semi equipment, materials, and software & services industry groups offset some of the outperformance compared to the Index. The top contributor to return was electronic equipment manufacturer, Samsung Electronics Co., Ltd. (South Korea). Other notable contributors included multinational luxury conglomerate, Kering SA (France), and household & personal care products company, Reckitt Benckiser Group Plc (United Kingdom). The largest detractor was home-appliance manufacturer, Whirlpool Corporation (United States). Additional notable detractors included paints & coatings producer, Akzo Nobel (Netherlands), and private-sector bank, AXIS Capital Holdings Ltd. (United States).

Investment Outlook

In Europe, we anticipate substantial economic benefits to begin materializing in 2026, as both the public and private sectors intensify investments in defense, security, energy, and infrastructure. The region’s initiatives to harmonize regulations and establish a unified, liquid capital market have the potential to significantly accelerate innovation and drive sustained economic growth. Moreover, the trade-weighted US dollar has reversed its late-2024 gains, reverting to levels last observed in early 2022. This depreciation may deliver further currency-related support to non-US markets, especially if real interest rates and economic growth outside the US remain steady or strengthen. If European leaders implement the competitiveness reforms proposed by Mario Draghi last year, our existing two-year price targets could prove conservative, particularly for portfolio holdings most sensitive to European economic growth. We continue to take a disciplined approach, favoring investments at current valuations rather than paying a premium for potential future positive developments.

Causeway’s global and international value portfolios focus on identifying undervalued stocks rather than positioning around macroeconomic trends. Given the valuation gap between US and non-US markets, we are aiming to find some of the most compelling investment opportunities across international markets. Our focus remains on identifying companies that offer durable value, characterized by pricing power, iconic brands, or robust product pipelines. Even the highest quality businesses can encounter temporary dislocations, which we view as opportunities to increase positions at attractive valuations. Recent external shocks have created such opportunities among select-high quality companies. The pharmaceutical industry faces a considerable list of challenges including US pricing, global trade restrictions, China’s economic slowdown, and uncertainties in drug pipelines. These challenges have created, in our view, value opportunities in some of the world’s top pharmaceutical firms where we remain confident in their ability to sustain cash flow, profit margins, and innovation over time. Across sectors, Causeway targets companies we believe are improving efficiency, driving earnings, and boosting cash flows.

The market commentary expresses the portfolio managers’ views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and the portfolio holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. The securities identified and described above do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable. Past performance does not guarantee future results. For a description of our performance attribution methodology, or to obtain a list showing every holding's contribution to the overall account's performance during the quarter, please contact our product manager, Kevin Moutes, at 310-231-6116 or [email protected].